Osteoporosis appears to be an often overlooked risk for men with prostate cancer who are having hormone therapy, says a study to be published in the Jan. 15 issue of Cancer.Researchers from Loyola University in Chicago examined data on 184 prostate cancer patients who had androgen-deprivation therapy, which is known to increase the risk of osteoporosis. The study found the majority of the men didn’t get osteoporosis prevention or treatment.
